Transient host range selection for genetic engineering of modified vaccinia virus Ankara

被引:72
作者
Staib, C [1 ]
Drexler, I [1 ]
Ohlmann, M [1 ]
Wintersperger, S [1 ]
Erfle, V [1 ]
Sutter, G [1 ]
机构
[1] GSF Munich, Inst Mol Virol, D-81675 Munich, Germany
关键词
D O I
10.2144/00286st04
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Recombinant vaccinia viruses are extremely valuable tools for research in molecular biology and immunology. The extension of vaccinia vector technology to replication deficient and safety-tested virus strains such as modified vaccinia virus Ankara (MVA) have made this versatile eukaryotic expression system even more attractive for basic and clinical research. Here, we report on easily obtaining recombinant MVA using stringent growth selection on rabbit kidney RK-13 cells. We describe the construction and use of new MVA vector plasmids that carry an expression cassette of the vaccinia virus host range gene, KIL, as a transient selectable marker: These plasmids allow either stable insertion of additional recombinant genes into the MVA genome or precisely targeted mutagenesis of MVA genomic sequences. Repetitive DNA sequences flanking the KIL gene were designed to remove the marker gene from the viral genome by homologous recombination under nonselective growth conditions. The convenience of this new selection technique is demonstrated by isolating MVA recombinants that produce green fluorescent protein and by generating MVA deletion mutants.
引用
收藏
页码:1137 / +
页数:9
相关论文
共 17 条
[1]   Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein [J].
Belyakov, IM ;
Wyatt, LS ;
Ahlers, JD ;
Earl, P ;
Pendleton, CD ;
Kelsall, BL ;
Strober, W ;
Moss, B ;
Berzofsky, JA .
JOURNAL OF VIROLOGY, 1998, 72 (10) :8264-8272
[2]  
CARROLL MW, 1995, BIOTECHNIQUES, V19, P352
[3]   Compact, synthetic, vaccinia virus early/late promoter for protein expression [J].
Chakrabarti, S ;
Sisler, JR ;
Moss, B .
BIOTECHNIQUES, 1997, 23 (06) :1094-1097
[4]  
Drexler I, 1999, CANCER RES, V59, P4955
[5]  
Drexler I, 2000, METH MOLEC MED, V35, P57, DOI 10.1385/1-59259-086-1:57
[6]   Dominant host range selection of vaccinia recombinants by rescue of an essential gene [J].
Holzer, GW ;
Gritschenberger, W ;
Mayrhofer, JA ;
Wieser, V ;
Dorner, F ;
Falkner, FG .
VIROLOGY, 1998, 249 (01) :160-166
[7]   GENERAL-METHOD FOR PRODUCTION AND SELECTION OF INFECTIOUS VACCINIA VIRUS RECOMBINANTS EXPRESSING FOREIGN GENES [J].
MACKETT, M ;
SMITH, GL ;
MOSS, B .
JOURNAL OF VIROLOGY, 1984, 49 (03) :857-864
[8]   MAPPING OF DELETIONS IN THE GENOME OF THE HIGHLY ATTENUATED VACCINIA VIRUS MVA AND THEIR INFLUENCE ON VIRULENCE [J].
MEYER, H ;
SUTTER, G ;
MAYR, A .
JOURNAL OF GENERAL VIROLOGY, 1991, 72 :1031-1038
[9]   Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety [J].
Moss, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (21) :11341-11348
[10]   CLONING AND EXPRESSION OF FOREIGN GENES IN VACCINIA VIRUS, USING A HOST RANGE SELECTION SYSTEM [J].
PERKUS, ME ;
LIMBACH, K ;
PAOLETTI, E .
JOURNAL OF VIROLOGY, 1989, 63 (09) :3829-3836